Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectabte squamous head and neck carcinoma

被引:68
作者
Salas, Sebastien [1 ]
Deville, Jean-Laurent [1 ]
Giorgi, Roch [2 ]
Pignon, Thierry [3 ]
Bagarry, Danielle [1 ]
Barrau, Karine [4 ]
Zanaret, Michel [5 ]
Giovanni, Antoine [5 ]
Bourgeois, Aude [1 ]
Favre, Roger [1 ]
Duffaud, Florence [1 ]
机构
[1] APHM, Adulte CHU Timone, Med Oncol Serv, F-13385 Marseille, France
[2] CHU Timone, Unite Biostat, Serv Sante Publ & Informat Med, Marseille, France
[3] APHM, Adulte CHU Timone, Serv Radiotherapie Oncol, F-13385 Marseille, France
[4] Lab Sante Publ, Marseille, France
[5] CHU Timone, Serv ORL Pediatrique & Chirurg Cervicofaciale, Marseille, France
关键词
head and neck carcinoma; radio-chemotherapy; nutritional factors; survival; response;
D O I
10.1016/j.radonc.2008.02.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study sought to evaluate nutritional prognostic factors before treatment in patients with unresectable head and neck cancer treated by concomitant radio-chemotherapy. Methods and materials: Seventy-two consecutive patients were treated. We studied the potential effects of CRP, Alb, preAlb, orosomucoid, weight, weight history, BMI, PINI, OPR and NRI on response to treatment, Event-Free Survival (EFS) and Overall Survival (OS). Effects of potential risk factors on OS and on EFS were analyzed by computing Kaplan-Meier estimates, and curves were compared using the log-rank test. Results: All biological nutritional factors were statistically correlated with the response to radio-chemotherapy. In multivariate analysis, only CRP (p = 0.004) remained statistically significant. A statistical correlation was found between Alb and EFS in multivariate analysis (p = 0.04). The factors influencing OS in univariate analysis were Alb (p = 0.008), CRP (p = 0.004), orosomucoid (p = 0.01) and NRI (p = 0.01), response to radio-chemotherapy (p < 0.001) and staging (p = 0.04). In multivariate analysis, only the response to radio-chemotherapy (p < 0.001) remained significant. Conclusions: This study illustrates the prognostic value of nutritional status. CRP and Alb may be useful in the assessment of advanced head and neck cancer patients at diagnosis and for stratifying patients taking part in randomized trials. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 56 条
[1]   Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [J].
Adelstein, DJ ;
Li, Y ;
Adams, GL ;
Wagner, H ;
Kish, JA ;
Ensley, JF ;
Schuller, DE ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :92-98
[2]  
Baghi M, 2006, ANTICANCER RES, V26, P559
[3]  
BALLOU SP, 1992, ADV INTERNAL MED, V37, P313
[4]   Predictors of weight loss during radiation therapy [J].
Beaver, ME ;
Matheny, KE ;
Roberts, DB ;
Myers, JN .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 125 (06) :645-648
[5]  
Bieri S, 2003, STRAHLENTHER ONKOL, V179, P390, DOI 10.1007/s00066-003-1077-1
[6]   Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck [J].
Bourhis, Jean ;
Rivera, Fernando ;
Mesia, Ricard ;
Awada, Ahmad ;
Geoffrois, Lionel ;
Borel, Christian ;
Humblet, Yves ;
Lopez-Pousa, Antonio ;
Hitt, Ricardo ;
Vega Villegas, M. Eugenia ;
Duck, Lionel ;
Rosine, Dominique ;
Amellal, Nadia ;
Schueler, Armin ;
Harstrick, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2866-2872
[7]   NUTRITIONAL-STATUS - A PROGNOSTIC INDICATOR IN HEAD AND NECK-CANCER [J].
BROOKES, GB .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1985, 93 (01) :69-74
[8]   Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma [J].
Calais, G ;
Alfonsi, M ;
Bardet, E ;
Sire, C ;
Germain, T ;
Bergerot, P ;
Rhein, B ;
Tortochaux, J ;
Oudinot, P ;
Bertrand, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) :2081-2086
[9]   OROSOMUCOID-PREALBUMIN RATIO - A MARKER OF THE HOST TUMOR RELATIONSHIP IN HEAD AND NECK-CANCER [J].
CALDANI, C ;
THYSS, A ;
SCHNEIDER, M ;
MILANO, G ;
BURAY, L ;
DEMARD, F .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04) :653-657
[10]  
CALDANI C, 1983, B CANCER, V70, P1